glp-1 clinic bay area Dr. Anand is back to share what you need to know about GLP-1s. The endocrinologist and obesity medicine specialist is here to discuss healthy maintenance habits for your weight loss journey, both GLP-1 weight loss can be

Epub 1993/07/01

Novo Nordisk, maker of the glucagon-like peptide-1 (GLP-1) agonist medication semaglutide (Wegovy), recently received accelerated approval from the U.S

Lancet 392:508520

Starting mid-2026, Medicare will cover injectable weight-loss medications including Ozempic, Wegovy, Mounjaro, and Zepbound for eligible individuals with severe obesity or related health conditions, at a cost of $245 per month to Medicare and a maximum $50 monthly copay for recipients

Health starts in the gut

It stimulates the release of growth hormone from the pituitary gland, which can have various effects on the body, including increasing muscle mass, reducing fat mass, and improving recovery from injuries